Cargando…
Mesenchymal Stem/Stromal Cell Therapy Is More Cost-Effective Than Fecal Diversion for Treatment of Perianal Crohn’s Disease Fistulas
Crohn’s disease (CD) is an inflammatory bowel disease with increasing incidence and prevalence worldwide. Perianal fistulas are seen in up to 26% of CD patients and are often refractory to medical therapy. Current treatments for CD perianal fistulas (pCD) include antibiotics, biologics, and for refr...
Autores principales: | Johnson, Sheeva, Hoch, Jeffrey S., Halabi, Wissam J., Ko, Jeffrey, Nolta, Jan, Dave, Maneesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248358/ https://www.ncbi.nlm.nih.gov/pubmed/35784367 http://dx.doi.org/10.3389/fimmu.2022.859954 |
Ejemplares similares
-
Efficacy and Safety of Mesenchymal Stem/Stromal Cell Therapy for Inflammatory Bowel Diseases: An Up-to-Date Systematic Review
por: Ko, Jeffrey Zheng-Hsien, et al.
Publicado: (2021) -
Mesenchymal Stromal Cell Therapy in the Management of Perianal Fistulas in Crohn’s Disease: An Up-To-Date Review
por: Gallo, Gaetano, et al.
Publicado: (2020) -
Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn’s Disease Perianal Fistulas
por: Barnhoorn, Marieke C, et al.
Publicado: (2020) -
Treatment of Perianal Crohn Disease Fistulae
por: Osterman, Mark T., et al.
Publicado: (2008) -
MRI of perianal fistulas in Crohn’s disease
por: Reginelli, Alfonso, et al.
Publicado: (2020)